Physician profile
Ron Feldman
NPI 1316123821
$28,603.43
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,139 · 2020: $2,445 · 2021: $6,200 · 2022: $6,628 · 2023: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,120 · Travel and Lodging: $838 · Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,120.00 |
| Travel and Lodging | $837.96 |
| Food and Beverage | $234.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Uk Limited | $8,387.16 | 2020-2023 | Fasenra |
| Janssen Research & Development, LLC | $7,440.00 | 2021-2022 | |
| Argenx US, INC. | $5,625.00 | 2022-2023 | Vyvgart |
| Galderma Laboratories, L.P. | $5,138.76 | 2019-2021 | |
| Grifols, S.A. | $2,000.00 | 2021-2022 | |
| Incyte Corporation | $12.51 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ron Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.